Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2010
02/23/2010US7666582 Immunoglobulin G-degrading enzyme for use as tool in diagnosis, prevention and treatment of streptococcal infection
02/23/2010US7666441 Nucleic acids encoding peptides having at least one biological activity of Can f I or Can f II, protein allergens of the species Canis familiaris; suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander
02/23/2010US7666436 Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
02/23/2010US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor
02/23/2010US7666414 Using modified anti-PSMA antibodies, or fragments thereof, to bind to human PSMA with high affinity and specificity; can be used as diagnostic, prophylactic, or therapeutic agents in vivo and in vitro
02/23/2010CA2347521C Method for producing chiral carboxylic acids from nitriles with the assistance of a nitrilase or microorganisms which contain a gene for the nitrilase
02/23/2010CA2198899C Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
02/23/2010CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor
02/18/2010WO2010019884A1 Methods and compositions for the detection of cancer
02/18/2010WO2010019847A2 Aptamer inhibition of thrombus formation
02/18/2010WO2010019446A1 Nucleic acid aptamers
02/18/2010WO2010019437A1 Alphavirus packaging cell lines
02/18/2010WO2010019434A1 Methods to treat and screen for agents to treat obesity
02/18/2010WO2010017598A1 Anti-il-12/il-23 antibodies
02/18/2010WO2008075364A3 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
02/18/2010WO2004084705A9 Quantitative detection of h. pylori in biological samples
02/18/2010US20100043105 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same
02/18/2010US20100043102 Nematode Inducible Promotors and Methods of Use
02/18/2010US20100043100 Polynucleotides for regulation of high level tissue-preferred expression in crop plants
02/18/2010US20100043099 Expression control elements from the lemnaceae family
02/18/2010US20100043098 Plant raffinose saccharide biosynthetic enzymes
02/18/2010US20100043084 Cotton varieties having a main stem load structure
02/18/2010US20100041875 Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric coplexes, and uses thereof
02/18/2010US20100041868 Conserved neisserial antigens
02/18/2010US20100041866 Solid Support Reagents for Synthesis
02/18/2010US20100041827 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
02/18/2010US20100041826 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
02/18/2010US20100041743 Transgenic animal with enhanced immune response and method for the preparation thereof
02/18/2010US20100041740 Flu vaccines and methods of use thereof
02/18/2010US20100041735 Modulation of toll-like receptor 3 expression by antisense oligonucleotides
02/18/2010US20100041734 Modulation of toll-like receptor 7 expression by antisense oligonucleotides
02/18/2010US20100041733 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION
02/18/2010US20100041614 Metastasis-specific peptides and their diagnostic and therapeutic applications
02/18/2010US20100041600 Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
02/18/2010US20100041596 Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor Receptors
02/18/2010US20100041595 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
02/18/2010US20100041144 Mammalian Cytokine; Related Reagents
02/18/2010US20100041140 Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof
02/18/2010US20100041138 IL-17 homologous polypeptides and therapeutic uses thereof
02/18/2010US20100041102 Antagonists of pcsk9
02/18/2010US20100041098 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
02/18/2010US20100041092 Drug controlled molecular tags
02/18/2010US20100041053 Proofreading primer extension
02/18/2010US20100041047 Efficient reduction of target rna's by single- and double-stranded oligomeric compounds
02/18/2010US20100041032 Composition and methods for the detection of cripto-3
02/18/2010US20100041029 Synthesis of four color 3'o-allyl, modified photocleavable fluorescent nucleotides and related methods
02/18/2010US20100041025 Compositons, methods and kits for real-time nucleic acid analysis in live cells
02/18/2010US20100041024 Bisulfite Conversion of DNA
02/18/2010US20100040651 Compositions and Methods for Vaccinating Against HSV-2
02/18/2010US20100040636 Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists
02/18/2010US20100040624 Human Tumor Necrosis Factor TR21 and Methods Based Thereon
02/18/2010US20100040621 Novel polpeptide and use thereof
02/18/2010US20100040611 Antagonists of pcsk9
02/18/2010US20100040610 Antagonists of pcsk9
02/18/2010US20100040606 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
02/18/2010US20100040602 Antibodies against Human Cytimegalovirus (HCMV)
02/18/2010US20100040597 Thrombin mutant
02/18/2010US20100040590 Tumor-associated peptides binding to human leukocyte antigen (HLA) class II molecules
02/18/2010US20100040578 Malignant Tumor Cell Suppressor Protein, Malignant Tumor Cell Suppressor Gene, Maligant Tumor Cell Suppressive Viral Vector, and Kit Using the Same
02/18/2010US20100040542 Chelator conjugates
02/18/2010US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases
02/18/2010CA2733642A1 Anti-il-12/il-23 antibodies
02/18/2010CA2732809A1 Aptamer inhibition of thrombus formation
02/17/2010EP2154144A1 Oligonucleotides and use thereof
02/17/2010EP2152911A1 Diagnosis of melanoma by nucleic acid analysis
02/17/2010EP2152723A1 Synthesis of oligonucleotides
02/17/2010EP2152316A2 Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory system
02/17/2010EP1578919B1 Endogenous retrovirus up-regulated in prostate cancer
02/17/2010EP1549322B1 Lipid a and other carbohydrate ligand analogs
02/17/2010EP1537227B1 Method for efficient rna interference in mammalian cells
02/17/2010EP1427852B1 Single nucleotide amplification and detection by polymerase
02/17/2010EP1421213B1 Labeled nucleoside polyphosphates
02/17/2010EP1383732B1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
02/17/2010EP1071700B1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
02/17/2010CN101652379A Recombinant expression vector elements (REVES) for enhancing expression of recombinant proteins in host cells
02/17/2010CN101652378A 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
02/17/2010CN101648985A Method for extracting DNA from acidic mine water bed mud in coal mine
02/16/2010USRE41129 Cytokine zalpha11 ligand polynucleotides
02/16/2010US7663036 Plants and seeds of hybrid corn variety CH945822
02/16/2010US7663031 Maize variety PHW2M
02/16/2010US7663024 P15 hairpin constructs and use
02/16/2010US7663020 Generation of plants with altered oil content
02/16/2010US7662952 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease
02/16/2010US7662951 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
02/16/2010US7662950 siRNA targeting myeloid differentiation primary response gene (88) (MYD88)
02/16/2010US7662949 Immunostimulatory oligoribonucleotides
02/16/2010US7662948 Antisense oligonucleotides against VR1
02/16/2010US7662947 Arabidopsis-stomatal-specific promoter and a genetic construct containing the promoter for expression of nucleic acids in plants
02/16/2010US7662946 Sequences encoding ADAMTS13 genes and proteins
02/16/2010US7662945 Expression vector comprising nucleotide sequences coding C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of vision defcets associated with cell proliferative disorders
02/16/2010US7662944 Nucleotide sequences coding prolyl dipeptidyl peptidase for use as tool in identifying modulators for prevention and treatment of activity neoplasia, type II diabetes, cirrhosis, autoimmunity, graft rejection and HIV infection
02/16/2010US7662942 Fluorescent quenching detection reagents and methods
02/16/2010US7662941 Embryonic stem cell self maintenance and renewal reporter
02/16/2010US7662940 Insecticidal proteins; insect resistance; transgenic plant, seeds and progeny
02/16/2010US7662939 Molecular determinants of tropism and virulence in enteroviruses
02/16/2010US7662938 2′-fluoronucleosides
02/16/2010US7662929 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis
02/16/2010US7662796 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
02/16/2010US7662794 DNA enzyme to inhibit plasminogen activator inhibitor-1
02/16/2010US7662793 Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter